ArticleScientific reports2025
A hybrid learning approach for MRI-based detection of alzheimer's disease stages using dual CNNs and ensemble classifier.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Applying ensemble machine learning techniques to MRI scans to predict Alzheimer's disease.Scientific reports · 2026Article
- Explainable Patient-Level Cognitive Impairment Screening via Temporal, Semantic, and Psycholinguistic Multimodal AI.Journal of Intelligence · 2026Article
- Integrating attractor dynamics and connectivity features for EEG-based dementia classification.Scientific reports · 2026Article
- Progression-Aware and Explainable CNN-Transformer Framework for Multiclass Alzheimer's Disease Staging Using MRI.Diagnostics (Basel, Switzerland) · 2026Article
- Artificial intelligence techniques for classification of Alzheimer's disease using neuroimaging data: a review.Frontiers in artificial intelligence · 2026Review
- Lightweight 3D CNN for MRI Analysis in Alzheimer's Disease: Balancing Accuracy and Efficiency.Journal of imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's Disease (AD) and related dementias are significant global health issues characterized by progressive cognitive decline and memory loss. Computer-aided systems can help physicians in the early and accurate detection of AD, enabling timely intervention and effective management. This study presents a combination of two parallel Convolutional Neural Networks (CNNs) and an ensemble learning method for classifying AD stages using Magnetic Resonance Imaging (MRI) data. Initially, these images were resized and augmented before being input into Network 1 and Network 2, which have different structures and layers to extract important features. These features were then fused and fed into an ensemble learning classifier containing Support Vector Machine, Random Forest, and K-Nearest Neighbors, with hyperparameters optimized by the Grid Search Cross-Validation technique. Considering distinct Network 1 and Network 2 along with ensemble learning, four classes were identified with accuracies of 95.16% and 97.97%, respectively. However, using the derived features from both networks resulted in an acceptable classification accuracy of 99.06%. These findings imply the potential of the proposed hybrid approach in the classification of AD stages. As the evaluation was conducted at the slice-level using a Kaggle dataset, additional subject-level validation and clinical testing are required to determine its real-world applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.